Short Stature Assessment in Children: A Fundamental Step Towards Early Diagnosis of Growth Failure
Thursday, March 17, 2016
6:00 PM-6:30 PM / Registration and Dinner
6:30 PM-8:00 PM / Meeting
HYATT REGENCY ATLANTA
Regency VII, Atrium Tower, Ballroom Level (LL1)
265 Peachtree Street, NE
Atlanta, GA 30303
Jan M. Foote, DNP, ARNP, CPNP, FAANP (Chair)
Pediatric Nurse Practitioner
Blank Children’s Endocrinology Clinic
Des Moines, IA
Adjunct Clinical Associate Professor
The University of Iowa College of Nursing
Iowa City, IA
Mitchell Geffner, MD
Chief of the Center for Endocrinology, Diabetes, and Metabolism
Children’s Hospital Los Angeles
Professor of Pediatrics
Keck School of Medicine
University of Southern California
Los Angeles, CA
After completing the CE/CME activity, learners should be better able to:
• Review how to measure and plot height, calculate growth velocity, mid-parental height, and target height and monitoring patients’
• Describe key elements of a patient’s history and physical examination to enhance the interpretation of growth patterns and differential diagnosis of growth disorders
• Discuss diagnostic criteria that trigger a specialist referral for confirmation of the diagnosis of growth-hormone deficiency or other diseases responsible for short stature and their management
This activity is intended to meet the educational needs of pediatric nurse practitioners (PNPs) and other pediatric-focused advanced practice registered nurses (APRNs).
This program is accredited for 1.5 NAPNAP CE contact hours per the National Association of Pediatric Nurse Practitioners Continuing Education Guidelines.
I. Identifying normal and abnormal growth patterns: growth failure versus short stature
A. Child’s growth curve
B. Genetic expectations for growth
C. Patterns of growth delay
II. Accurate and timely diagnosis of children with growth deficiencies
A. Overview of normal growth rates during childhood
B. Causes of growth delay
C. Intrinsic short stature versus delayed or attenuated growth
III. Timely referral to a specialist
A. Diagnostic criteria for the patient with growth deficiency
V .Questions and answers
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact: NAPNAP at firstname.lastname@example.org.
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
Med Learning Group has been given meeting space to provide an educational offering during NAPNAP’s National Conference. NAPNAP’s approval of meeting space or continuing education accreditation does not imply product endorsement.
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at email@example.com
Feel free to pass this invitation on to your colleagues that you believe would be interested in attending this free CE program. However, all attendees must be registered for NAPNAP’s National Conference in order to attend.
This activity is provided by Med Learning Group.
Accredited by NAPNAP.
Supported by an Educational Grant from Novo Nordisk